SLC66A3
Solute carrier family 66 member 3
Also known as: C2orf22, MGC33602, PQLC3, S66A3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N755
- Gene
- SLC66A3
- Ensembl
- ENSG00000162976
- Chromosome
- 2
- Canonical length
- 202 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
202 residues, UniProt reviewed canonical sequence.
>Q8N755|SLC66A3
1 MEAALLGLCN WSTLGVCAAL KLPQISAVLA ARSARGLSLP SLLLELAGFL VFLRYQCYYG
61 YPPLTYLEYP ILIAQDVILL LCIFHFNGNV KQATPYIAVL VSSWFILALQ KWIIDLAMNL
121 CTFISAASKF AQLQCLWKTR DSGTVSALTW SLSSYTCATR IITTLMTTND FTILLRFVIM
181 LALNIWVTVT VLRYRKTAIK AELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC66A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 45 nTPM
- spleen: 38 nTPM
- cervix: 36 nTPM
- ovary: 33 nTPM
- adipose tissue: 31 nTPM
- pancreas: 28 nTPM
Single-cell type
- kupffer cells: 129 nCPM
- extravillous trophoblasts: 117 nCPM
- oocytes: 83 nCPM
- decidual stromal cells: 82 nCPM
- epididymal clear cells: 74 nCPM
- hepatic stellate cells: 71 nCPM
Immune cell
- non-classical monocyte: 209 nTPM
- intermediate monocyte: 195 nTPM
- total PBMC: 166 nTPM
- classical monocyte: 154 nTPM
- myeloid DC: 154 nTPM
- eosinophil: 151 nTPM
Brain region
- choroid plexus: 23 nTPM
- white matter: 17 nTPM
- medulla oblongata: 13 nTPM
- spinal cord: 12 nTPM
- pons: 10 nTPM
- thalamus: 9.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.82
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC66A3 as an antibody target. Whether an autoantibody or antibody against SLC66A3 could matter depends on whether native SLC66A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC66A3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC66A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...